Public interest group accuses FDA of trying to discredit whistleblower

BMJ 2004; 329 doi: (Published 25 November 2004) Cite this as: BMJ 2004;329:1255
  1. Jeanne Lenzer
  1. New York

    A public interest group that aims to protect whistleblowers claimed last week that an attempt had been made by a member of staff at the Food and Drug Administration to discredit Dr David Graham, the FDA executive who testified to the US Senate committee on 18 November.

    Dr Graham, associate director in the FDA's Office of Drug Safety, had carried out a study with Kaiser Permanente of northern California that looked …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription